2020
DOI: 10.3389/fgene.2020.00171
|View full text |Cite
|
Sign up to set email alerts
|

DNA Methylation Biomarkers in Aging and Age-Related Diseases

Abstract: Recent research efforts provided compelling evidence of genome-wide DNA methylation alterations in aging and age-related disease. It is currently well established that DNA methylation biomarkers can determine biological age of any tissue across the entire human lifespan, even during development. There is growing evidence suggesting epigenetic age acceleration to be strongly linked to common diseases or occurring in response to various environmental factors. DNA methylation based clocks are proposed as biomarke… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
116
2
4

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 173 publications
(126 citation statements)
references
References 136 publications
(139 reference statements)
1
116
2
4
Order By: Relevance
“…These differences have been interpreted to reflect different speeds of biological aging, and can even be used to predict all-cause mortality 26 . Furthermore, many pathological conditions are associated with epigenetic age acceleration in humans, while anti-aging diets in mice have been shown to result in age deceleration 24 , 27 . The available findings in humans and mice thus suggest that differences between methylation age and chronological age can be used as health biomarkers, with age acceleration indicating poor health and age deceleration indicating good health.…”
Section: Introductionmentioning
confidence: 99%
“…These differences have been interpreted to reflect different speeds of biological aging, and can even be used to predict all-cause mortality 26 . Furthermore, many pathological conditions are associated with epigenetic age acceleration in humans, while anti-aging diets in mice have been shown to result in age deceleration 24 , 27 . The available findings in humans and mice thus suggest that differences between methylation age and chronological age can be used as health biomarkers, with age acceleration indicating poor health and age deceleration indicating good health.…”
Section: Introductionmentioning
confidence: 99%
“…Data now show it is possible to determine someone’s epigenetic age and compare it with their chronological age. There is a close correlation with this ratio and co-existing morbidity [ 287 ]. Thus, would blood-derived epigenetic markers of metabolic age correlate with disease severity before, during and after infection?…”
Section: Can We Test the Hypothesis That Mitochondrial Health = Immunmentioning
confidence: 99%
“… 6 , 143 This can be explained by the upregulation of ACE2 expression by Estrogen, 4 , 131 and the X-chromosomal location of the ACE2 gene 3 , 129 , 144 (which is regulated epigenetically via DNA methylation). 12 , 13 DNA methylation is associated with biological age, 12 , 145 , 146 which suggests that biological age may be a more accurate risk factor for severe COVID-19 complications compared to chronological age. 13 , 147 This pattern of ACE2 expression may partly explain why elevated ACE2 levels possibly have no negative effects on COVID-19 susceptibility.…”
Section: Renin Angiotensin Aldosterone Systemmentioning
confidence: 99%